Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics and Immunogenicity of the First Doses of PEG-Asparaginase -An ALLTogether Pilot Study

NCT04843150 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT04843150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04843150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics and Immunogenicity of the First Doses of PEG-Asparaginase -An ALLTogether Pilot Study
Lead sponsor
Aarhus University Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2020
Completion date
October 1, 2023
Enrollment
320 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia